Loading stock data...

Concord Biotech Limited

NSE: CONCORDBIO BSE: CONCORDBIO

NSE
1,712.30 -9.60 (-0.56%)

Prev Close

1721.9

Open Price

1749

Volume

167,947

Today Low / High

1701 / 1749

52 WK Low / High

1327.05 / 2664

Range

1,627 - 1,798

BSE
1,711.50 -8.15 (-0.47%)

Prev Close

1719.65

Open Price

1719

Volume

796

Today Low / High

1705.35 / 1734.5

52 WK Low / High

1326.9 / 2658

Range

1,626 - 1,797

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 1712.3 (target range: 1,627 - 1,798), reflecting a change of -9.6 (-0.55752%). On the BSE, it is listed at 1711.5 (target range: 1,626 - 1,797), showing a change of -8.15 (-0.47393%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.

21 Apr 1,749.00 -2.10%
17 Apr 1,741.30 -1.11%
16 Apr 1,730.00 0.65%
15 Apr 1,700.00 1.95%
11 Apr 1,643.45 0.63%
09 Apr 1,617.00 -0.71%
08 Apr 1,605.80 -0.58%
07 Apr 1,570.00 0.77%
04 Apr 1,736.00 -4.57%
03 Apr 1,696.60 1.43%
02 Apr 1,658.10 2.32%
01 Apr 1,655.40 0.45%
28 Mar 1,746.40 -3.77%
27 Mar 1,675.00 2.72%
26 Mar 1,705.00 -3.00%
25 Mar 1,686.90 0.22%
24 Mar 1,680.00 -1.05%

Concord Biotech Limited Graph

Concord Biotech Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Concord Biotech Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,712.30, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 1,711.50 1,728.62 1,555.75 - 1,901.48
1,745.73 1,396.58 - 2,094.88
1,762.85 1,233.99 - 2,291.70
Bearish Scenario 1,711.50 1,694.39 1,524.95 - 1,863.82
1,677.27 1,341.82 - 2,012.72
1,660.16 1,162.11 - 2,158.20

Overview of Concord Biotech Limited

ISIN

INE338H01029

Industry

Biotechnology

Vol.Avg

176,736

Market Cap

179,134,319,260

Last Dividend

8.75

Official Website

Visit Website

IPO Date

2023-08-18

DCF Diff

1,624.95

DCF

95

Financial Ratios Every Investor Needs

Stock Dividend of CONCORDBIO

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2024-06-21 June 21, 24 8.75 8.75 2024-06-22 2024-07-29

Stock Rating Details for CONCORDBIO

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 3 Neutral
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2024-03-31 998.06 Cr 244.78 Cr 753.27 Cr 0.7547 22.90 Cr 11.13 Cr 626.19 Cr 308.10 Cr 29.45 465.91 Cr 0.3087
2023-03-31 853.17 Cr 180.21 Cr 672.96 Cr 0.7888 32.83 Cr 10.50 Cr 326.52 Cr 240.09 Cr 22.95 383.22 Cr 0.2814
2022-03-31 708.44 Cr 177.92 Cr 530.52 Cr 0.7489 29.09 Cr 10.58 Cr 243.96 Cr 174.93 Cr 16.72 297.34 Cr 0.2469
2021-03-31 604.05 Cr 120.33 Cr 483.73 Cr 0.8008 0.00 Cr 7.09 Cr 306.89 Cr 234.89 Cr 22.45 341.74 Cr 0.3889
2020-03-31 512.33 Cr 138.08 Cr 374.25 Cr 0.7305 0.00 Cr 6.30 Cr 194.00 Cr 169.11 Cr 16.16 214.05 Cr 0.3301

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2024-03-31 15.14 Cr 1,700.71 Cr 174.06 Cr 1,526.6455 Cr 9.74 Cr -5.40 Cr 207.95 Cr 786.48 Cr 3.66 Cr 0.00 Cr -263.36 Cr 142.1554 Cr
2023-03-31 3.50 Cr 1,513.98 Cr 223.98 Cr 1,290.0010 Cr 31.55 Cr 28.05 Cr 212.32 Cr 765.48 Cr 0.00 Cr 0.00 Cr -168.12 Cr 191.8460 Cr
2022-03-31 0.67 Cr 1,312.80 Cr 209.57 Cr 1,103.2230 Cr 62.49 Cr 61.83 Cr 195.12 Cr 643.56 Cr 0.00 Cr 0.00 Cr -160.85 Cr 155.1680 Cr
2021-03-31 5.14 Cr 1,182.55 Cr 183.17 Cr 999.3730 Cr 89.28 Cr 84.14 Cr 153.61 Cr 557.75 Cr 0.00 Cr 0.00 Cr -195.70 Cr 105.7390 Cr
2020-03-31 45.62 Cr 940.52 Cr 170.28 Cr 648.5830 Cr 50.96 Cr 5.34 Cr 111.23 Cr 380.91 Cr 0.00 Cr 0.00 Cr 0.82 Cr 115.0950 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2024-03-31 265.4671 Cr -154.6093 Cr -99.2149 Cr 179.7786 Cr 11.6429 Cr 15.1421 Cr -85.6885 Cr 308.1032 Cr -26.5036 Cr -71.4529 Cr 4.3609 Cr
2023-03-31 246.0018 Cr -157.9501 Cr -85.2194 Cr 100.9170 Cr 2.8323 Cr 3.4992 Cr -145.0848 Cr 322.0134 Cr -26.5961 Cr -53.5635 Cr -17.2273 Cr
2022-03-31 207.4750 Cr -111.7880 Cr -100.1640 Cr 51.9700 Cr -4.4770 Cr 0.6670 Cr -155.5050 Cr 237.5180 Cr -26.6557 Cr -70.5210 Cr -41.5090 Cr
2021-03-31 166.8170 Cr -195.2050 Cr 31.1240 Cr -37.3590 Cr 2.7360 Cr 5.1440 Cr -204.1760 Cr 312.7200 Cr 38.3210 Cr -5.7060 Cr -42.3770 Cr
2020-03-31 154.8440 Cr -112.7790 Cr -43.4160 Cr -0.6230 Cr -1.3510 Cr 2.4080 Cr -155.4670 Cr 169.1120 Cr 37.4200 Cr -80.5450 Cr -19.5140 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2024-12-31 244.22 Cr 52.40 Cr 191.82 Cr 0.7854 84.69 Cr 75.92 Cr 7.26 114.51 Cr 0.3109
2024-09-30 310.18 Cr 76.32 Cr 233.86 Cr 0.7540 123.36 Cr 95.74 Cr 9.15 143.75 Cr 0.3087
2024-06-30 215.80 Cr 48.30 Cr 167.50 Cr 0.7762 135.84 Cr 59.59 Cr 5.70 91.59 Cr 0.2761
2024-03-31 318.97 Cr 88.84 Cr 230.13 Cr 0.7215 129.18 Cr 95.02 Cr 9.08 145.10 Cr 0.2979
2023-12-31 240.80 Cr 47.09 Cr 193.71 Cr 0.8045 103.60 Cr 77.57 Cr 7.41 114.12 Cr 0.3222

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2024-09-30 7.40 Cr 310.89 Cr 318.29 Cr 0.00 Cr 250.42 Cr 934.65 Cr 806.03 Cr 1,764.34 Cr 173.97 Cr
2024-06-30 -281.67 Cr 563.33 Cr 281.67 Cr 0.00 Cr 0.00 Cr 281.67 Cr 0.00 Cr 0.00 Cr -1,526.65 Cr
2024-03-31 15.14 Cr 295.03 Cr 310.18 Cr 369.04 Cr 207.95 Cr 896.23 Cr 786.48 Cr 1,700.71 Cr 174.06 Cr
2023-12-31 -225.07 Cr 450.14 Cr 225.07 Cr 0.00 Cr 0.00 Cr 225.07 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-09-30 6.08 Cr 245.49 Cr 251.56 Cr 267.04 Cr 219.86 Cr 755.65 Cr 777.60 Cr 1,551.03 Cr 196.72 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-06-30 59.59 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 95.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 77.57 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-09-30 81.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-06-30 54.49 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Biotechnology

Company Name Symbol Price Market Cap Volume
Biocon Limited BIOCON ₹331.90 ₹398,479,140,000.00 ₹1,860,996.00
Piramal Pharma Limited PPLPHARMA ₹220.76 ₹292,672,172,632.00 ₹3,206,567.00
Syngene International Limited SYNGENE ₹724.60 ₹290,777,127,354.00 ₹309,960.00
Concord Biotech Limited CONCORDBIO ₹1,712.30 ₹179,134,319,260.00 ₹167,947.00
Blue Jet Healthcare Limited BLUEJET ₹742.40 ₹128,780,727,808.00 ₹402,801.00
Jubilant Ingrevia Limited JUBLINGREA ₹674.95 ₹107,506,805,443.00 ₹165,388.00
Supriya Lifescience Limited SUPRIYA ₹743.80 ₹59,863,106,640.00 ₹485,094.00
Dishman Carbogen Amcis Limited DCAL ₹210.73 ₹33,038,902,663.00 ₹169,506.00
Panacea Biotec Limited PANACEABIO ₹504.80 ₹30,919,375,571.00 ₹556,110.00
Zota Health Care Limited ZOTA ₹884.35 ₹24,657,917,174.00 ₹61,116.00

Key Executives

Chief Financial Officer
Mr. Lalit Sethi

Gender: male

Year Born:

Chairman & MD
Mr. Sudhir Jairam Vaid

Gender: male

Year Born: 1952

General Manager, International Business Development
Sundeep Bengani

Gender: Not Specified

Year Born:

Vice President of Formulation Division & Head of Valthera Unit-2
Mr. Manoj Kumar

Gender: male

Year Born:

Company Secretary, Compliance Officer & Assistant Vice President of Finance
Mr. Prakash Lalchand Sajnani

Gender: male

Year Born:

Joint MD, Chief Executive Officer & Director
Mr. Ankur Vaid

Gender: male

Year Born: 1982

Vice President of Sales & Marketing and Head of Limbasi Plant-3
Mr. Devang Bhatt

Gender: male

Year Born:

FAQs about Concord Biotech Limited

Who is the CEO of the company?

The CEO is Mr. Ankur Vaid.

What is the current market price of the stock?

The current price is ₹1,712.30.

What is the 52-week price range?

The range is ₹1327.05-2664.

What is the market capitalization of the company?

The market capitalization is ₹17,913.43 crores.

What is the dividend yield?

The dividend yield is 0.51%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 54.88.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Concord Biotech Limited (ISIN: INE338H01029) is a leading Biotechnology in India. With a market capitalization of ₹17,913.43 crores and an average daily volume of 176,736 shares, it operates in the Biotechnology. The company last declared a dividend of ₹8.75.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack